Resources

Industry Articles

Stay in the know with insight directly from industry experts and decision-makers.

Cell Line Selection Predicted to Shift to CMOs, Double Digit Increase in Demand for the Service Press

Cell Line Selection Predicted to Shift to CMOs, Double Digit Increase in Demand for the Service

New report defines which biologic manufacturing capabilities are needed Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – October 12, 2016 – A new report from Industry Standard Research (ISR), Bioprocessing Services and Technologies Market Trends and…
ISR Reports
Sponsors and CROs Agree that Integrating Statistical Modeling and Knowledge of Past Performance into Feasibility Analyses Improves Accuracy of Results Press

Sponsors and CROs Agree that Integrating Statistical Modeling and Knowledge of Past Performance into Feasibility Analyses Improves Accuracy of Results

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – August 30, 2016 – A new report, Best Practices in Study Feasibility, from Industry Standard Research (ISR) reveals insights into how to successfully navigate many of the challenges—medical,…
ISR Reports
New ISR Report Reveals Current and Future Dynamics in Phase II/III Market, Changes Expected in Clinical Trial Spend Press

New ISR Report Reveals Current and Future Dynamics in Phase II/III Market, Changes Expected in Clinical Trial Spend

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – June 21, 2016 – Industry Standard Research has released its comprehensive new report, “Phase II/III Study Trends and Market Outlook (2016-2020),” concerning the trends, resource allocation, and market…
ISR Reports
Two-thirds of Biopharma Sponsors Surveyed Currently Sell or Plan to Sell Biosimilar Products Press

Two-thirds of Biopharma Sponsors Surveyed Currently Sell or Plan to Sell Biosimilar Products

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – May 17, 2016 – A new report titled Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices (3rd edition), from Industry Standard Research (ISR), indicates that the majority of…
ISR Reports
ISR’s New Report Provides Common Structures, Models for Pharma’s Regulatory Affairs Departments Press

ISR’s New Report Provides Common Structures, Models for Pharma’s Regulatory Affairs Departments

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – March 29, 2016 – Industry Standard Research (ISR) today announced a new addition to its Department Models and Structures suite of reports.  The new report aims to provide…
ISR Reports